Global Radiopharmaceuticals for Diagnosis Supply, Demand and Key Producers, 2024-2030
Page: 152
Published Date: 30 Aug 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
The global Radiopharmaceuticals for Diagnosis market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global Radiopharmaceuticals for Diagnosis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals for Diagnosis and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals for Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceuticals for Diagnosis total production and demand, 2019-2030, (K Units)
Global Radiopharmaceuticals for Diagnosis total production value, 2019-2030, (USD Million)
Global Radiopharmaceuticals for Diagnosis production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Radiopharmaceuticals for Diagnosis consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Radiopharmaceuticals for Diagnosis domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceuticals for Diagnosis production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Radiopharmaceuticals for Diagnosis production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radiopharmaceuticals for Diagnosis production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Radiopharmaceuticals for Diagnosis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Beijing Zhibo High-tech Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals for Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Radiopharmaceuticals for Diagnosis Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Radiopharmaceuticals for Diagnosis Market, Segmentation by Type:
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Global Radiopharmaceuticals for Diagnosis Market, Segmentation by Application:
Hospital
Clinic
Other
Companies Profiled:
Atom High-tech Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
Tianjin Said Biopharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
RadioMedix, Inc.
Lantheus
Key Questions Answered:
1. How big is the global Radiopharmaceuticals for Diagnosis market?
2. What is the demand of the global Radiopharmaceuticals for Diagnosis market?
3. What is the year over year growth of the global Radiopharmaceuticals for Diagnosis market?
4. What is the production and production value of the global Radiopharmaceuticals for Diagnosis market?
5. Who are the key producers in the global Radiopharmaceuticals for Diagnosis market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Radiopharmaceuticals for Diagnosis Introduction
1.2 World Radiopharmaceuticals for Diagnosis Supply & Forecast
1.2.1 World Radiopharmaceuticals for Diagnosis Production Value (2019 & 2023 & 2030)
1.2.2 World Radiopharmaceuticals for Diagnosis Production (2019-2030)
1.2.3 World Radiopharmaceuticals for Diagnosis Pricing Trends (2019-2030)
1.3 World Radiopharmaceuticals for Diagnosis Production by Region (Based on Production Site)
1.3.1 World Radiopharmaceuticals for Diagnosis Production Value by Region (2019-2030)
1.3.2 World Radiopharmaceuticals for Diagnosis Production by Region (2019-2030)
1.3.3 World Radiopharmaceuticals for Diagnosis Average Price by Region (2019-2030)
1.3.4 North America Radiopharmaceuticals for Diagnosis Production (2019-2030)
1.3.5 Europe Radiopharmaceuticals for Diagnosis Production (2019-2030)
1.3.6 China Radiopharmaceuticals for Diagnosis Production (2019-2030)
1.3.7 Japan Radiopharmaceuticals for Diagnosis Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceuticals for Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceuticals for Diagnosis Major Market Trends
2.1 World Radiopharmaceuticals for Diagnosis Demand (2019-2030)
2.2 World Radiopharmaceuticals for Diagnosis Consumption by Region
2.2.1 World Radiopharmaceuticals for Diagnosis Consumption by Region (2019-2024)
2.2.2 World Radiopharmaceuticals for Diagnosis Consumption Forecast by Region (2025-2030)
2.3 United States Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.4 China Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.5 Europe Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.6 Japan Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.7 South Korea Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.8 ASEAN Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
2.9 India Radiopharmaceuticals for Diagnosis Consumption (2019-2030)
3.1 World Radiopharmaceuticals for Diagnosis Production Value by Manufacturer (2019-2024)
3.2 World Radiopharmaceuticals for Diagnosis Production by Manufacturer (2019-2024)
3.3 World Radiopharmaceuticals for Diagnosis Average Price by Manufacturer (2019-2024)
3.4 Radiopharmaceuticals for Diagnosis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Radiopharmaceuticals for Diagnosis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals for Diagnosis in 2023
3.5.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals for Diagnosis in 2023
3.6 Radiopharmaceuticals for Diagnosis Market: Overall Company Footprint Analysis
3.6.1 Radiopharmaceuticals for Diagnosis Market: Region Footprint
3.6.2 Radiopharmaceuticals for Diagnosis Market: Company Product Type Footprint
3.6.3 Radiopharmaceuticals for Diagnosis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Radiopharmaceuticals for Diagnosis Production Value Comparison
4.1.1 United States VS China: Radiopharmaceuticals for Diagnosis Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Radiopharmaceuticals for Diagnosis Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Radiopharmaceuticals for Diagnosis Production Comparison
4.2.1 United States VS China: Radiopharmaceuticals for Diagnosis Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Radiopharmaceuticals for Diagnosis Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Radiopharmaceuticals for Diagnosis Consumption Comparison
4.3.1 United States VS China: Radiopharmaceuticals for Diagnosis Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Radiopharmaceuticals for Diagnosis Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Radiopharmaceuticals for Diagnosis Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value (2019-2024)
4.4.3 United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production (2019-2024)
4.5 China Based Radiopharmaceuticals for Diagnosis Manufacturers and Market Share
4.5.1 China Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value (2019-2024)
4.5.3 China Based Manufacturers Radiopharmaceuticals for Diagnosis Production (2019-2024)
4.6 Rest of World Based Radiopharmaceuticals for Diagnosis Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production (2019-2024)
5.1 World Radiopharmaceuticals for Diagnosis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Technetium 99mTc Dithiodithiocarbamate
5.2.2 Technetium 99mTc Polymerized Albumin
5.2.3 Technetium 99mTc Pentetate
5.2.4 Strontium 89Sr Chloride
5.2.5 Iodine 125I Sealed Seed Source
5.2.6 Sodium Iodide 131I
5.2.7 Other
5.3 Market Segment by Type
5.3.1 World Radiopharmaceuticals for Diagnosis Production by Type (2019-2030)
5.3.2 World Radiopharmaceuticals for Diagnosis Production Value by Type (2019-2030)
5.3.3 World Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2030)
6.1 World Radiopharmaceuticals for Diagnosis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Radiopharmaceuticals for Diagnosis Production by Application (2019-2030)
6.3.2 World Radiopharmaceuticals for Diagnosis Production Value by Application (2019-2030)
6.3.3 World Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2030)
7.1 Atom High-tech Co., Ltd.
7.1.1 Atom High-tech Co., Ltd. Details
7.1.2 Atom High-tech Co., Ltd. Major Business
7.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Atom High-tech Co., Ltd. Recent Developments/Updates
7.1.6 Atom High-tech Co., Ltd. Competitive Strengths & Weaknesses
7.2 Shanghai Xinke Pharmaceutical Co., Ltd.
7.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Details
7.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Major Business
7.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
7.2.6 Shanghai Xinke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
7.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Details
7.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Major Business
7.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
7.3.6 Guangdong Xi'ai Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
7.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Details
7.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Major Business
7.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product and Services
7.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
7.4.6 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Competitive Strengths & Weaknesses
7.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
7.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Details
7.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Major Business
7.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5.6 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.6 Chengdu Yunke Pharmaceutical Co., Ltd.
7.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Details
7.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Major Business
7.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
7.6.6 Chengdu Yunke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
7.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Details
7.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Major Business
7.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7.6 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
7.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Details
7.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Major Business
7.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
7.8.6 Shenzhen Larven Bioengineering Technology Co., Ltd. Competitive Strengths & Weaknesses
7.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
7.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Details
7.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Major Business
7.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
7.9.6 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Competitive Strengths & Weaknesses
7.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
7.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Details
7.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Major Business
7.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
7.10.6 Beijing Zhibo High-tech Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.11 Tianjin Said Biopharmaceutical Co., Ltd.
7.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Details
7.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Major Business
7.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Tianjin Said Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
7.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Details
7.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Major Business
7.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
7.12.6 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Competitive Strengths & Weaknesses
7.13 Chengdu Xinke Pharmaceutical Co., Ltd.
7.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Details
7.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Major Business
7.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
7.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
7.13.6 Chengdu Xinke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.14 Jubilant Radiopharma
7.14.1 Jubilant Radiopharma Details
7.14.2 Jubilant Radiopharma Major Business
7.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product and Services
7.14.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Jubilant Radiopharma Recent Developments/Updates
7.14.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
7.15 PDRadiopharma Inc.
7.15.1 PDRadiopharma Inc. Details
7.15.2 PDRadiopharma Inc. Major Business
7.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product and Services
7.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 PDRadiopharma Inc. Recent Developments/Updates
7.15.6 PDRadiopharma Inc. Competitive Strengths & Weaknesses
7.16 GE Healthcare Ltd
7.16.1 GE Healthcare Ltd Details
7.16.2 GE Healthcare Ltd Major Business
7.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product and Services
7.16.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 GE Healthcare Ltd Recent Developments/Updates
7.16.6 GE Healthcare Ltd Competitive Strengths & Weaknesses
7.17 DOE IP
7.17.1 DOE IP Details
7.17.2 DOE IP Major Business
7.17.3 DOE IP Radiopharmaceuticals for Diagnosis Product and Services
7.17.4 DOE IP Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 DOE IP Recent Developments/Updates
7.17.6 DOE IP Competitive Strengths & Weaknesses
7.18 RadioMedix, Inc.
7.18.1 RadioMedix, Inc. Details
7.18.2 RadioMedix, Inc. Major Business
7.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product and Services
7.18.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 RadioMedix, Inc. Recent Developments/Updates
7.18.6 RadioMedix, Inc. Competitive Strengths & Weaknesses
7.19 Lantheus
7.19.1 Lantheus Details
7.19.2 Lantheus Major Business
7.19.3 Lantheus Radiopharmaceuticals for Diagnosis Product and Services
7.19.4 Lantheus Radiopharmaceuticals for Diagnosis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Lantheus Recent Developments/Updates
7.19.6 Lantheus Competitive Strengths & Weaknesses
8.1 Radiopharmaceuticals for Diagnosis Industry Chain
8.2 Radiopharmaceuticals for Diagnosis Upstream Analysis
8.2.1 Radiopharmaceuticals for Diagnosis Core Raw Materials
8.2.2 Main Manufacturers of Radiopharmaceuticals for Diagnosis Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Radiopharmaceuticals for Diagnosis Production Mode
8.6 Radiopharmaceuticals for Diagnosis Procurement Model
8.7 Radiopharmaceuticals for Diagnosis Industry Sales Model and Sales Channels
8.7.1 Radiopharmaceuticals for Diagnosis Sales Model
8.7.2 Radiopharmaceuticals for Diagnosis Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Radiopharmaceuticals for Diagnosis Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Radiopharmaceuticals for Diagnosis Production Value by Region (2019-2024) & (USD Million)
Table 3. World Radiopharmaceuticals for Diagnosis Production Value by Region (2025-2030) & (USD Million)
Table 4. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Region (2019-2024)
Table 5. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Region (2025-2030)
Table 6. World Radiopharmaceuticals for Diagnosis Production by Region (2019-2024) & (K Units)
Table 7. World Radiopharmaceuticals for Diagnosis Production by Region (2025-2030) & (K Units)
Table 8. World Radiopharmaceuticals for Diagnosis Production Market Share by Region (2019-2024)
Table 9. World Radiopharmaceuticals for Diagnosis Production Market Share by Region (2025-2030)
Table 10. World Radiopharmaceuticals for Diagnosis Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Radiopharmaceuticals for Diagnosis Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Radiopharmaceuticals for Diagnosis Major Market Trends
Table 13. World Radiopharmaceuticals for Diagnosis Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Radiopharmaceuticals for Diagnosis Consumption by Region (2019-2024) & (K Units)
Table 15. World Radiopharmaceuticals for Diagnosis Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Radiopharmaceuticals for Diagnosis Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceuticals for Diagnosis Producers in 2023
Table 18. World Radiopharmaceuticals for Diagnosis Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Radiopharmaceuticals for Diagnosis Producers in 2023
Table 20. World Radiopharmaceuticals for Diagnosis Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Radiopharmaceuticals for Diagnosis Company Evaluation Quadrant
Table 22. World Radiopharmaceuticals for Diagnosis Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Radiopharmaceuticals for Diagnosis Production Site of Key Manufacturer
Table 24. Radiopharmaceuticals for Diagnosis Market: Company Product Type Footprint
Table 25. Radiopharmaceuticals for Diagnosis Market: Company Product Application Footprint
Table 26. Radiopharmaceuticals for Diagnosis Competitive Factors
Table 27. Radiopharmaceuticals for Diagnosis New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceuticals for Diagnosis Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceuticals for Diagnosis Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Radiopharmaceuticals for Diagnosis Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Radiopharmaceuticals for Diagnosis Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share (2019-2024)
Table 37. China Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Radiopharmaceuticals for Diagnosis Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share (2019-2024)
Table 42. Rest of World Based Radiopharmaceuticals for Diagnosis Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share (2019-2024)
Table 47. World Radiopharmaceuticals for Diagnosis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Radiopharmaceuticals for Diagnosis Production by Type (2019-2024) & (K Units)
Table 49. World Radiopharmaceuticals for Diagnosis Production by Type (2025-2030) & (K Units)
Table 50. World Radiopharmaceuticals for Diagnosis Production Value by Type (2019-2024) & (USD Million)
Table 51. World Radiopharmaceuticals for Diagnosis Production Value by Type (2025-2030) & (USD Million)
Table 52. World Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Radiopharmaceuticals for Diagnosis Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Radiopharmaceuticals for Diagnosis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Radiopharmaceuticals for Diagnosis Production by Application (2019-2024) & (K Units)
Table 56. World Radiopharmaceuticals for Diagnosis Production by Application (2025-2030) & (K Units)
Table 57. World Radiopharmaceuticals for Diagnosis Production Value by Application (2019-2024) & (USD Million)
Table 58. World Radiopharmaceuticals for Diagnosis Production Value by Application (2025-2030) & (USD Million)
Table 59. World Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Radiopharmaceuticals for Diagnosis Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Atom High-tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Atom High-tech Co., Ltd. Major Business
Table 63. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 64. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Atom High-tech Co., Ltd. Recent Developments/Updates
Table 66. Atom High-tech Co., Ltd. Competitive Strengths & Weaknesses
Table 67. Shanghai Xinke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Shanghai Xinke Pharmaceutical Co., Ltd. Major Business
Table 69. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 70. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 72. Shanghai Xinke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 73. Guangdong Xi'ai Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Guangdong Xi'ai Pharmaceutical Co., Ltd. Major Business
Table 75. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 76. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 78. Guangdong Xi'ai Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 79. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 80. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Major Business
Table 81. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product and Services
Table 82. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
Table 84. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Competitive Strengths & Weaknesses
Table 85. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Major Business
Table 87. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 88. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Chengdu Yunke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Chengdu Yunke Pharmaceutical Co., Ltd. Major Business
Table 93. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 94. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 96. Chengdu Yunke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 97. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Major Business
Table 99. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 100. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 102. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Shenzhen Larven Bioengineering Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Shenzhen Larven Bioengineering Technology Co., Ltd. Major Business
Table 105. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 106. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
Table 108. Shenzhen Larven Bioengineering Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Major Business
Table 111. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 112. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
Table 114. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 115. Beijing Zhibo High-tech Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Zhibo High-tech Biotechnology Co., Ltd. Major Business
Table 117. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 118. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
Table 120. Beijing Zhibo High-tech Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 121. Tianjin Said Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Tianjin Said Biopharmaceutical Co., Ltd. Major Business
Table 123. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 124. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Tianjin Said Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 127. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Major Business
Table 129. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 130. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
Table 132. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Competitive Strengths & Weaknesses
Table 133. Chengdu Xinke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Chengdu Xinke Pharmaceutical Co., Ltd. Major Business
Table 135. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 136. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 138. Chengdu Xinke Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 140. Jubilant Radiopharma Major Business
Table 141. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product and Services
Table 142. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Jubilant Radiopharma Recent Developments/Updates
Table 144. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 145. PDRadiopharma Inc. Basic Information, Manufacturing Base and Competitors
Table 146. PDRadiopharma Inc. Major Business
Table 147. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product and Services
Table 148. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. PDRadiopharma Inc. Recent Developments/Updates
Table 150. PDRadiopharma Inc. Competitive Strengths & Weaknesses
Table 151. GE Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 152. GE Healthcare Ltd Major Business
Table 153. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product and Services
Table 154. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. GE Healthcare Ltd Recent Developments/Updates
Table 156. GE Healthcare Ltd Competitive Strengths & Weaknesses
Table 157. DOE IP Basic Information, Manufacturing Base and Competitors
Table 158. DOE IP Major Business
Table 159. DOE IP Radiopharmaceuticals for Diagnosis Product and Services
Table 160. DOE IP Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. DOE IP Recent Developments/Updates
Table 162. DOE IP Competitive Strengths & Weaknesses
Table 163. RadioMedix, Inc. Basic Information, Manufacturing Base and Competitors
Table 164. RadioMedix, Inc. Major Business
Table 165. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product and Services
Table 166. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. RadioMedix, Inc. Recent Developments/Updates
Table 168. RadioMedix, Inc. Competitive Strengths & Weaknesses
Table 169. Lantheus Basic Information, Manufacturing Base and Competitors
Table 170. Lantheus Major Business
Table 171. Lantheus Radiopharmaceuticals for Diagnosis Product and Services
Table 172. Lantheus Radiopharmaceuticals for Diagnosis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Lantheus Recent Developments/Updates
Table 174. Lantheus Competitive Strengths & Weaknesses
Table 175. Global Key Players of Radiopharmaceuticals for Diagnosis Upstream (Raw Materials)
Table 176. Global Radiopharmaceuticals for Diagnosis Typical Customers
Table 177. Radiopharmaceuticals for Diagnosis Typical Distributors
List of Figures
Figure 1. Radiopharmaceuticals for Diagnosis Picture
Figure 2. World Radiopharmaceuticals for Diagnosis Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Radiopharmaceuticals for Diagnosis Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Radiopharmaceuticals for Diagnosis Production (2019-2030) & (K Units)
Figure 5. World Radiopharmaceuticals for Diagnosis Average Price (2019-2030) & (US$/Unit)
Figure 6. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Region (2019-2030)
Figure 7. World Radiopharmaceuticals for Diagnosis Production Market Share by Region (2019-2030)
Figure 8. North America Radiopharmaceuticals for Diagnosis Production (2019-2030) & (K Units)
Figure 9. Europe Radiopharmaceuticals for Diagnosis Production (2019-2030) & (K Units)
Figure 10. China Radiopharmaceuticals for Diagnosis Production (2019-2030) & (K Units)
Figure 11. Japan Radiopharmaceuticals for Diagnosis Production (2019-2030) & (K Units)
Figure 12. Radiopharmaceuticals for Diagnosis Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 15. World Radiopharmaceuticals for Diagnosis Consumption Market Share by Region (2019-2030)
Figure 16. United States Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 17. China Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 18. Europe Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 19. Japan Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 20. South Korea Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 22. India Radiopharmaceuticals for Diagnosis Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Radiopharmaceuticals for Diagnosis by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals for Diagnosis Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals for Diagnosis Markets in 2023
Figure 26. United States VS China: Radiopharmaceuticals for Diagnosis Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Radiopharmaceuticals for Diagnosis Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Radiopharmaceuticals for Diagnosis Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share 2023
Figure 30. China Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Radiopharmaceuticals for Diagnosis Production Market Share 2023
Figure 32. World Radiopharmaceuticals for Diagnosis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Type in 2023
Figure 34. Technetium 99mTc Dithiodithiocarbamate
Figure 35. Technetium 99mTc Polymerized Albumin
Figure 36. Technetium 99mTc Pentetate
Figure 37. Strontium 89Sr Chloride
Figure 38. Iodine 125I Sealed Seed Source
Figure 39. Sodium Iodide 131I
Figure 40. Other
Figure 41. World Radiopharmaceuticals for Diagnosis Production Market Share by Type (2019-2030)
Figure 42. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Type (2019-2030)
Figure 43. World Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2030) & (US$/Unit)
Figure 44. World Radiopharmaceuticals for Diagnosis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 45. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Application in 2023
Figure 46. Hospital
Figure 47. Clinic
Figure 48. Other
Figure 49. World Radiopharmaceuticals for Diagnosis Production Market Share by Application (2019-2030)
Figure 50. World Radiopharmaceuticals for Diagnosis Production Value Market Share by Application (2019-2030)
Figure 51. World Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2030) & (US$/Unit)
Figure 52. Radiopharmaceuticals for Diagnosis Industry Chain
Figure 53. Radiopharmaceuticals for Diagnosis Procurement Model
Figure 54. Radiopharmaceuticals for Diagnosis Sales Model
Figure 55. Radiopharmaceuticals for Diagnosis Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Atom High-tech Co., Ltd. Shanghai Xinke Pharmaceutical Co., Ltd. Guangdong Xi'ai Pharmaceutical Co., Ltd. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Chengdu Yunke Pharmaceutical Co., Ltd. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Shenzhen Larven Bioengineering Technology Co., Ltd. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Beijing Zhibo High-tech Biotechnology Co., Ltd. Tianjin Said Biopharmaceutical Co., Ltd. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Chengdu Xinke Pharmaceutical Co., Ltd. Jubilant Radiopharma PDRadiopharma Inc. GE Healthcare Ltd DOE IP RadioMedix, Inc. Lantheus
30 Aug 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
